Search For "phase 3"
WHO Africa to look into dozens of COVID-19 herbal remedies to be tested in
Updated : 5 years, 5 months ago IST
Geneva [Switzerland], October 2 (ANI/Sputnik): The African Regional Expert Committee on Traditional Medicine for COVID-19 will gather soon to pick the most promising herbal medicine products against the disease, which under the newly adopted protocol put forth by the World Health Organizatio
Read More
HDFC Life launches 'Futurance' Phase 3 to incubate startups in association
Updated : 5 years, 5 months ago IST
Mumbai (Maharashtra) [India], October 1 (ANI/NewsVoir): HDFC Life, one of India's leading life insurance companies and IvyCamp, an initiative of IvyCap Ventures, today jointly launched the third phase of Futurance - the corporate engagement program to identify startups that are building i
Read More
COVID-19: Phase-3 trial of COVAXIN to begin in UP's Lucknow, Gorakhpur fro
Updated : 5 years, 5 months ago IST
Lucknow (Uttar Pradesh) [India], September 25 (ANI): The Uttar Pradesh government on Thursday announced that phase-3 trial of the coronavirus vaccine 'COVAXIN' will start in Lucknow and Gorakhpur from October.
Read More
Three Government Medical Colleges in Punjab to participate in phase 3 COVA
Updated : 5 years, 5 months ago IST
Chandigarh (Punjab) [India], September 22 (ANI): Three Government Medical Colleges in Punjab will participate in the phase 3 trials of the COVAXIN being tested by Bharat Biotech Ltd in collaboration with the Indian Council of Medical Research (ICMR) against COVID-19, said a statement from th
Read More
First Russian volunteers inoculated with China's COVID-19 vaccine
Updated : 5 years, 5 months ago IST
Moscow [Russia], September 21 (ANI/Sputnik): Russian pharmaceutical company Petrovax launched phase 3 clinical trials of the Chinese Covid-19 vaccine candidate, CanSino Biologics Ad5-nCoV, on the first group of Russian volunteers in Moscow, the company said on Monday.
Read More
Serum Institute all set to begin phase 3 trials of Covid-19 vaccine
Updated : 5 years, 5 months ago IST
Pune (Maharashtra) [India], September 19 (ANI): Serum Institute of India (SII) is all set to begin phase three trials of the Covishield Vaccine developed by AstraZeneca and Oxford University at Sassoon General Hospital in Pune, the hospital administration said on Saturday.
Read More
Oxford vaccine phase 3 trials resume after halt over safety concerns
Updated : 5 years, 6 months ago IST
London [UK], September 12 (ANI): The third phase of AstraZeneca's coronavirus vaccine trial has resumed in the UK, days after it was halted over safety concerns.
Read More
AstraZeneca says COVID-19 vaccine trial paused due to unexplained illness
Updated : 5 years, 6 months ago IST
London [UK], September 9 (ANI): UK-based biopharma giant AstraZeneca has said that the phase 3 testing of its COVID-19 vaccine being developed with Oxford University has been put on hold, due to a suspected serious adverse reaction in a participant in the United Kingdom.
Read More
Significant movement on Russia's offer for phase 3 testing, manufacture of
Updated : 5 years, 6 months ago IST
New Delhi [India], September 8 (ANI): With Russia approaching India for phase 3 trials of its Sputnik V vaccine against COVID-19 and for its manufacture in the country, NITI Aayog member Dr VK Paul said on Tuesday that the government attaches "great importance to this offer of partnership
Read More
50,000 people taking part in phase 3 trial of Chinese COVID-19 Vaccine
Updated : 5 years, 6 months ago IST
Beijing [China], August 05 (ANI/Sputnik): Around 50,000 people in a number of countries are participating in phase 3 clinical trials of a coronavirus vaccine developed by the China National Biotec Group (CNBG), the company said on Saturday in a press release.
Read More
AstraZeneca's vaccine has reached Phase 3 clinical trials in US: Trump
Updated : 5 years, 6 months ago IST
Washington DC [USA], Sep 1 (ANI): US President Donald Trump on Monday announced AstraZeneca's COVID-19 vaccine has reached Phase 3 clinical trials in the United States and is very close to being finalised for approval.
Read More
COVID-19: Subject Expert Committee seeks DCGI's nod to use hepatitis injec
Updated : 5 years, 6 months ago IST
New Delhi [India], Aug 19 (ANI): The Subject Expert Committee (SEC) at the Central Drugs Standard Control Organisation (CDSCO) has recommended that the country's top drug regulator grant permission for phase 3 clinical trial using Thymosin @-1 injection 1.6 mg on moderate to severe COVID-19
Read More